Suchergebnisse - "Leticia Huergo-Zapico"

PubPharm (6)

1

Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia

in: OncoImmunology | 2017

von Mónica Villa-Álvarez | Seila Lorenzo-Herrero | Ana P. Gonzalez-Rodriguez | +5

2

NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?

in: Journal of Immunology Research | 2016

von Claudia Cantoni | Leticia Huergo-Zapico | Monica Parodi | +9

3

Pleiotropic Anti-Angiogenic and Anti-Oncogenic Activities of the Novel Mithralog Demycarosyl-3D-ß-D-Digitoxosyl-Mithramycin SK (EC-8042).

in: PLoS ONE | 2015

von Azahara Fernández-Guizán | Alejandro López-Soto | Andrea Acebes-Huerta | +5

4

Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease.

in: PLoS ONE | 2014

von Leticia Huergo-Zapico | Andrea Acebes-Huerta | Ana Pilar Gonzalez-Rodriguez | +7

5

Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells

in: BioMed Research International | 2014

von Andrea Acebes-Huerta | Leticia Huergo-Zapico | Ana Pilar Gonzalez-Rodriguez | +4

6

Lenalidomide and Chronic Lymphocytic Leukemia

in: BioMed Research International | 2013

von Ana Pilar González-Rodríguez | Angel R. Payer | Andrea Acebes-Huerta | +4

1
[1]